These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 18304658)

  • 41. Dissecting Impulsivity: Brain Mechanisms and Neuropsychiatric Implications.
    Robbins TW; Dalley JW
    Nebr Symp Motiv; 2017; 64():201-226. PubMed ID: 30351564
    [No Abstract]   [Full Text] [Related]  

  • 42. Essential fatty acids and their role in the treatment of impulsivity disorders.
    Hallahan B; Garland MR
    Prostaglandins Leukot Essent Fatty Acids; 2004 Oct; 71(4):211-6. PubMed ID: 15301790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive remediation in the treatment of stimulant abuse disorders: a research agenda.
    Vocci FJ
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):484-97. PubMed ID: 19086769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroreceptor mechanisms of aggression and its treatment.
    Swann AC
    J Clin Psychiatry; 2003; 64 Suppl 4():26-35. PubMed ID: 12672262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
    Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
    Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
    Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
    Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropharmacological modulation of cognition.
    Chamberlain SR; Müller U; Robbins TW; Sahakian BJ
    Curr Opin Neurol; 2006 Dec; 19(6):607-12. PubMed ID: 17102701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relations of serotonin function to personality: current views and a key methodological issue.
    Carver CS; Miller CJ
    Psychiatry Res; 2006 Sep; 144(1):1-15. PubMed ID: 16914207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches.
    Congdon E; Canli T
    Behav Cogn Neurosci Rev; 2005 Dec; 4(4):262-81. PubMed ID: 16585800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging role of glutamate in the pathophysiology of major depressive disorder.
    Hashimoto K
    Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Varieties of impulsivity.
    Evenden JL
    Psychopharmacology (Berl); 1999 Oct; 146(4):348-61. PubMed ID: 10550486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of serotonin in impulsive and aggressive behaviors associated with epilepsy-like neuronal hyperexcitability in the amygdala.
    Keele NB
    Epilepsy Behav; 2005 Nov; 7(3):325-35. PubMed ID: 16103019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the field of cannabinoid--opioid cross-talk.
    Robledo P; Berrendero F; Ozaita A; Maldonado R
    Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry.
    Dalley JW; Mar AC; Economidou D; Robbins TW
    Pharmacol Biochem Behav; 2008 Aug; 90(2):250-60. PubMed ID: 18272211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory control deficits in childhood and risk for substance use disorders: a review.
    Ivanov I; Schulz KP; London ED; Newcorn JH
    Am J Drug Alcohol Abuse; 2008; 34(3):239-58. PubMed ID: 18428067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
    Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
    Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inattentive symptoms of ADHD are related to evening orientation.
    Caci H; Bouchez J; Baylé FJ
    J Atten Disord; 2009 Jul; 13(1):36-41. PubMed ID: 19387003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 5-HTTLPR polymorphism modulates the association of serious life events (SLE) and impulsivity in patients with Borderline Personality Disorder.
    Wagner S; Baskaya O; Lieb K; Dahmen N; Tadić A
    J Psychiatr Res; 2009 Sep; 43(13):1067-72. PubMed ID: 19358998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of ADHD symptoms on performance monitoring in a non-clinical population.
    Herrmann MJ; Saathoff C; Schreppel TJ; Ehlis AC; Scheuerpflug P; Pauli P; Fallgatter AJ
    Psychiatry Res; 2009 Sep; 169(2):144-8. PubMed ID: 19700203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain γ-aminobutyric acid: a neglected role in impulsivity.
    Hayes DJ; Jupp B; Sawiak SJ; Merlo E; Caprioli D; Dalley JW
    Eur J Neurosci; 2014 Jun; 39(11):1921-32. PubMed ID: 24460847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.